Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
204.6 GBX | -0.87% | +4.98% | +8.08% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 07 | IWG confident of meeting expectations amid subdued start to year | AN |
Sales 2024 * | 3.29B 4.18B | Sales 2025 * | 3.54B 4.5B | Capitalization | 2.06B 2.62B |
---|---|---|---|---|---|
Net income 2024 * | 15M 19.05M | Net income 2025 * | 68M 86.36M | EV / Sales 2024 * | 2.42 x |
Net Debt 2024 * | 5.92B 7.52B | Net Debt 2025 * | 5.74B 7.28B | EV / Sales 2025 * | 2.2 x |
P/E ratio 2024 * |
146
x | P/E ratio 2025 * |
38
x | Employees | 10,000 |
Yield 2024 * |
0.78% | Yield 2025 * |
1.65% | Free-Float | 67.74% |
Latest transcript on IWG plc
1 day | -0.87% | ||
1 week | +4.98% | ||
Current month | +10.06% | ||
1 month | +12.79% | ||
3 months | +1.89% | ||
6 months | +34.43% | ||
Current year | +8.08% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Dixon
FOU | Founder | 64 | 88-12-31 |
Charlie Steel
DFI | Director of Finance/CFO | 39 | 22-08-31 |
Thomas Sinclair
CIO | Chief Investment Officer | - | 16-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nina Henderson
BRD | Director/Board Member | 72 | 14-05-19 |
Mark Dixon
FOU | Founder | 64 | 88-12-31 |
François Pauly
BRD | Director/Board Member | 59 | 15-05-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 204.6 | -0.87% | 12,982,830 |
24-05-16 | 206.4 | +0.68% | 2,872,207 |
24-05-15 | 205 | +2.86% | 2,823,726 |
24-05-14 | 199.3 | -0.30% | 514,509 |
24-05-13 | 199.9 | +2.57% | 963,752 |
Delayed Quote London S.E., May 17, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.08% | 2.62B | |
+12.50% | 4.4B | |
+71.85% | 374M | |
+11.88% | 280M | |
+7.69% | 121M | |
+24.84% | 77.03M |
- Stock Market
- Equities
- IWG Stock